Stocks and Investing
Stocks and Investing
Tue, January 17, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Colin Langan Maintained (ADNT) at Buy with Increased Target to $46 on, Jan 17th, 2023
Colin Langan of Wells Fargo, Maintained "Adient plc" (ADNT) at Buy with Increased Target from $41 to $46 on, Jan 17th, 2023.
Colin has made no other calls on ADNT in the last 4 months.
There are 4 other peers that have a rating on ADNT. Out of the 4 peers that are also analyzing ADNT, 2 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Rosner of "Deutsche Bank" Downgraded from Strong Buy to Hold and Held Target at $39 on, Tuesday, November 8th, 2022
- Joseph Spak of "RBC Capital" Downgraded from Buy to Hold and Held Target at $36 on, Monday, November 7th, 2022
These are the ratings of the 2 analyists that currently disagree with Colin
- John Murphy of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $52 on, Monday, January 9th, 2023
- Adam Jonas of "Morgan Stanley" Maintained at Sell with Increased Target to $29 on, Monday, November 28th, 2022
Contributing Sources